| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Migalovich HS et al. | Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media. | 2009 | Cancer Res. | pmid:19509228 |
| Urban VM et al. | Superficial distribution and identification of antifungal/antimicrobial agents on a modified tissue conditioner by SEM-EDS microanalysis: a preliminary study. | 2009 | J Prosthodont | pmid:19515168 |
| Van Cutsem J | The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. | 1991 | Am. J. Obstet. Gynecol. | pmid:1951575 |
| Ribeiro MG et al. | Phenotypic and genotypic characterization of Prototheca zopfii in a dog with enteric signs. | 2009 | Res. Vet. Sci. | pmid:19520405 |
| Mlot C | Microbiology. Antibiotics in nature: beyond biological warfare. | 2009 | Science | pmid:19556482 |
| Rosato A et al. | In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species. | 2009 | Phytomedicine | pmid:19616925 |
| de la Borbolla JM et al. | Late reaction to oral nystatin: the importance of patch testing. | 2009 | J Investig Allergol Clin Immunol | pmid:19639730 |
| Maldonado-Celis ME et al. | Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19666002 |
| Jared SR et al. | Actions of antidiuretic hormone analogues on intact and nystatin-permeabilized frog skins. | 2009 | Exp. Physiol. | pmid:19666695 |
| Bernstein JM and Aucott W | The BIPP introducer. | 2009 | Clin Otolaryngol | pmid:19674006 |
| Harvey AL and Marshall IG | The actions of three diaminopyridines on the chick biventer cervicis muscle. | 1977 | Eur. J. Pharmacol. | pmid:196864 |
| Sakeer K et al. | Use of xanthan and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. | 2010 Jul-Aug | Pharm Dev Technol | pmid:19772376 |
| Kaomongkolgit R et al. | Antifungal activity of alpha-mangostin against Candida albicans. | 2009 | J Oral Sci | pmid:19776506 |
| Scardina GA et al. | Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin. | 2009 | J Oral Sci | pmid:19776507 |
| Austin N et al. | Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. | 2009 | Cochrane Database Syst Rev | pmid:19821309 |
| Zhang Y et al. | A marine sulfate-reducing bacterium producing multiple antibiotics: biological and chemical investigation. | 2009 | Mar Drugs | pmid:19841718 |
| Kang YS et al. | Clathrin-independent internalization of normal cellular prion protein in neuroblastoma cells is associated with the Arf6 pathway. | 2009 | J. Cell. Sci. | pmid:19843586 |
| Záruba K et al. | Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. | 1991 | Am. J. Kidney Dis. | pmid:1986569 |
| BÃlková E et al. | Targeted antifungal delivery system: beta-glucosidase sensitive nystatin-star poly(ethylene glycol) conjugate. | 2010 | Int J Pharm | pmid:19874880 |
| Muñante-Cárdenas JL et al. | Treating oral histoplasmosis in an immunocompetent patient. | 2009 | J Am Dent Assoc | pmid:19884394 |
| Bernbeck B et al. | Long time survival after reduced chemotherapy ina 15-year-old patient with AML and Candida krusei sepsis and eye involvement. | 2009 Nov-Dec | Klin Padiatr | pmid:19890793 |
| Ogita A et al. | Targeted yeast vacuole disruption by polyene antibiotics with a macrocyclic lactone ring. | 2010 | Int. J. Antimicrob. Agents | pmid:19910165 |
| de Aguiar MM et al. | Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. | 2010 | Drug Dev Ind Pharm | pmid:19954405 |
| Preobrazhenskaya MN et al. | Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). | 2010 | J. Antibiot. | pmid:19960041 |
| Woo KY et al. | Peristomal skin complications and management. | 2009 | Adv Skin Wound Care | pmid:20026934 |
| Jacobs WR et al. | Role of cytosolic Ca in renal tubule damage induced by anoxia. | 1991 | Am. J. Physiol. | pmid:2003577 |
| Young JP et al. | Acetylsalicylic acid enhances purinergic receptor-mediated outward currents in rat megakaryocytes. | 2010 | Am. J. Physiol., Cell Physiol. | pmid:20042731 |
| Ulrych A et al. | Dissociation of nystatin and amphotericin analogues: characterisation of minor anti-fungal macrolides. | 2010 | Eur J Mass Spectrom (Chichester, Eng) | pmid:20065516 |
| Semis R et al. | Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds. | 2010 | Mycopathologia | pmid:20069459 |
| Dagnino L et al. | Sodium-dependent nucleoside transport in mouse leukemia L1210 cells. | 1991 | J. Biol. Chem. | pmid:2007583 |
| Samaranayake YH et al. | The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata. | 2010 | Med. Mycol. | pmid:20092419 |
| MartÃnez-Beneyto Y et al. | Use of antifungal agents for oral candidiasis: results of a national survey. | 2010 | Int J Dent Hyg | pmid:20096082 |
| Peacock G et al. | Accuracy and precision of manufacturer-supplied liquid medication administration devices before and after patient education. | 2010 Jan-Feb | J Am Pharm Assoc (2003) | pmid:20097644 |
| Hirota H et al. | YS-822A, a new polyene macrolide antibiotic. II. Planar structure of YS-822A. | 1991 | J. Antibiot. | pmid:2010357 |
| Shamsul HM et al. | The Toll-like receptor 2 (TLR2) ligand FSL-1 is internalized via the clathrin-dependent endocytic pathway triggered by CD14 and CD36 but not by TLR2. | 2010 | Immunology | pmid:20113368 |
| Dalben-Dota KF et al. | Antifungal activity of propolis extract against yeasts isolated from vaginal exudates. | 2010 | J Altern Complement Med | pmid:20192913 |
| Mete E et al. | Synthesis and antifungal activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols. | 2010 | Arch. Pharm. (Weinheim) | pmid:20232370 |
| A controlled trial of nystatin for the candidiasis hypersensitivity syndrome. | 1991 | N. Engl. J. Med. | pmid:2027363 | |
| Böckle BC et al. | Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). | 2010 | J. Am. Acad. Dermatol. | pmid:20304522 |
| López-MartÃnez R | Candidosis, a new challenge. | 2010 | Clin. Dermatol. | pmid:20347660 |
| te Welscher YM et al. | Natamycin inhibits vacuole fusion at the priming phase via a specific interaction with ergosterol. | 2010 | Antimicrob. Agents Chemother. | pmid:20385867 |
| Fan SR and Liu XP | In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. | 2011 | Mycoses | pmid:20406393 |
| Field EA | Discontinuation concern. | 2010 | Br Dent J | pmid:20448592 |
| Levenson C et al. | Preventing postoperative burn wound aspergillosis. | 1991 Mar-Apr | J Burn Care Rehabil | pmid:2050719 |
| Pontes HA et al. | Oral candidiasis mimicking an oral squamous cell carcinoma: report of a case. | 2012 | Gerodontology | pmid:20633054 |
| Aydemir C et al. | Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. | 2011 | Arch. Dis. Child. Fetal Neonatal Ed. | pmid:20659937 |
| Yap FB et al. | Penicillium marneffei infection in an African man. | 2010 | Dermatol. Online J. | pmid:20673530 |
| Chanteloup NK et al. | The extra-intestinal avian pathogenic Escherichia coli strain BEN2908 invades avian and human epithelial cells and survives intracellularly. | 2011 | Vet. Microbiol. | pmid:20708353 |
| Rae J et al. | Low access resistance perforated patch recordings using amphotericin B. | 1991 | J. Neurosci. Methods | pmid:2072734 |
| Schilling T and Eder C | Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. | 2010 | Cell. Immunol. | pmid:20832779 |